Information on new approvals and medication safety that rheumatologists need to know
Pharmacy-based Arthritis Screening Debuts in Canada
Co-sponsored program between the Ministry of Health and pharmacy chain tasks pharmacists with screening people for knee osteoarthritis
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
2013 ACR/ARHP Annual Meeting: Researchers Explore Role of Pathogens, Quality of Care in Rheumatoid Arthritis
Funding by the Rheumatology Research Foundation has furthered studies on the impact of infectious agents and autoantigens, periodontal disease, and disease-modifying antirheumatic drugs on patients with RA
2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review
Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
EULAR 2013: New RA Recommendations Address Combination Therapy Concerns
Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment
How to Manage Pain in Patients with Renal Insufficiency or End-Stage Renal Disease on Dialysis
Narcotic and non-narcotic pain regimens can be used
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
EULAR 2013: Drugs New and Old Could Treat Spondylarthropies
Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored
- « Previous Page
- 1
- …
- 110
- 111
- 112
- 113
- 114
- …
- 122
- Next Page »